Synlett 2010(4): 654-658  
DOI: 10.1055/s-0029-1219341
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

New Methodologies for the Synthesis of 3-Acylpyridone Metabolites

Raymond C. F. Jones*a, Abdul K. Choudhurya, James N. Ileyb, Georgia Loizoub, Christopher Lumleya, Vickie McKeea
a Chemistry Department, Loughborough University, Loughborough, Leics LE11 3TU, UK
Fax: +44(1509)223925; e-Mail: r.c.f.jones@lboro.ac.uk;
b Chemistry Department, The Open University, Walton Hall, Milton Keynes MK7 6AA, UK
Further Information

Publication History

Received 23 November 2009
Publication Date:
19 January 2010 (online)

Abstract

A core isoxazolo[4,3-c]pyridin-4-one scaffold is prepared and elaborated at C-3(Me) and C-7 as a masked building block for 3-acylpyridin-2-ones related to the acylpyridone natural products

    References and Notes

  • 1a El Basyouni SH. Brewer D. Vining LC. Can. J. Bot.  1968,  46:  441 
  • 1b Wat C.-K. McInnes AG. Smith DG. Can. J. Chem.  1977,  55:  4090 
  • 2 Cheng Y. Schneider B. Riese U. Schubert B. Li Z. Hamburger M. J. Nat. Prod.  2004,  67:  1854 
  • 3a Schmidt K. Gunther W. Stoyanova S. Schubert B. Li Z. Hamburger M. Org. Lett.  2002,  4:  197 
  • 3b Schmidt K. Riese U. Li Z. Hamburger M. J. Nat. Prod.  2003,  66:  378 
  • 4a Takahashi S. Kakinuma N. Uchida K. Hashimoto R. Yanagisawa T. Nakagawa A. J. Antibiot.  1998,  51:  596 
  • 4b Takahashi S. Kakinuma N. Uchida K. Hashimoto R. Yanagisawa T. Nakagawa A. J. Antibiot.  1998,  51:  1051 
  • 5 Matsumoto M. Minato H. Tetrahedron Lett.  1976,  42:  3827 
  • 6 For leading references, see: Dolle RE. Nicolaou KC. J. Am. Chem. Soc.  1985,  107:  1691 
  • 7a Halo LM. Marshall JM. Yakasai AA. Song Z. Butts CP. Crump MP. Heneghan M. Bailey AM. Simpson TJ. Lazarus CM. Cox RJ. ChemBioChem  2008,  9:  585 
  • 7b Halo LM. Heneghan MN. Yakasai AA. Song Z. Williams K. Bailey AM. Cox RJ. Lazarus CM. Simpson TJ. J. Am. Chem. Soc.  2008,  130:  17988 
  • 8a Jones RCF. Dawson CE. O’Mahony MJ. Patel P. Tetrahedron Lett.  1999,  40:  4085 
  • 8b Jones RCF. Pillainayagam TA. Synlett  2004,  2815 
  • 8c Law CCM. PhD Thesis   Loughborough University; UK: 2008. 
  • For our first-generation approach, see:
  • 9a Jones RCF. Bhalay G. Carter PA. Duller KAM. Dunn SH.
    J. Chem. Soc., Perkin Trans. 1  1999,  765 
  • 9b Jones RCF. Duller KAM. Vulto SIE. J. Chem. Soc., Perkin Trans. 1  1998,  411 
  • 9c Jones RCF. Duller KAM. ARKIVOC  2002,  (viii):  34 
  • 10a Natale NR. McKenna JI. Niou C. Borth M. J. Org. Chem.  1985,  50:  5660 
  • 10b Grünanger P. Vita-Finzi P. Isoxazoles: The Chemistry of Heterocyclic Compounds   Part 1, Vol. 49:  Wiley-Interscience; New York: 1991.  p.324 
  • 11 Stork G. McMurry JE. J. Am. Chem. Soc.  1967,  89:  5461 
  • 12 Phan XT. Shannon PJ. J. Org. Chem.  1983,  48:  5164 
  • 15 Moore MC. Cox RJ. Duffin GR. O’Hagan D. Tetrahedron  1998,  54:  9195 
  • 17a Loizou G. PhD Thesis   The Open University; UK: 2006. 
  • 17b

    Choudhury, A. K. unpublished results.

  • 18 Nitta M. Kobayashi T. J. Chem. Soc., Chem. Commun.  1982,  877 
  • 19 Jones RCF. Bhalay G. Carter PA. J. Chem. Soc., Perkin Trans. 1  1993,  1715 
13

Typical ProcedureSynthesis of 3-Methyl-7-phenyl-5 H -isoxazolo[4,3- c ]pyridin-4-one (12a)
Pd(PPh3)4 (4.2 mg, 0.004 mmol) was added to degassed 1,4-dioxane (10 mL), followed by iodopyridone 11 (20 mg, 0.07 mmol). The solution was purged with N2 for 10 min at 23 ˚C. Phenylboronic acid (13 mg, 0.1 mmol) in EtOH (10 mL) and aq Na2CO3 (2 M, 0.02 mL, 0.14 mmol) were degassed with N2, and added sequentially. The mixture was heated at reflux for 18 h under an N2 atmosphere, cooled, H2O (50 mL) added, and the mixture was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with brine (50 mL), dried (MgSO4), filtered, and evaporated under reduced pressure to a brown oil purified by silica column chromatography eluting with EtOAc-light PE (bp 40-60 ˚C) (1:1 v/v) to leave title compound 12a, white solid (10 mg, 67%); mp 253.5-254 ˚C. IR (CH2Cl2): νmax = 3245, 2959, 1676, 1629, 1404 cm. ¹H NMR (400 MHz, CDCl3): δ = 2.86 (3 H, s, CH3), 7.33 (1 H, d, J = 6.0 Hz, NHCH), 7.36 (1 H, t, J = 7.2 Hz, ArCH), 7.43 (2 H, m, ArCH), 7.75 (2 H, d, J = 7.2 Hz, ArCH), 8.72 (1 H, br, NH). ¹³C NMR (100 MHz, CDCl3): δ = 13.0 (CH3), 108.6, 112.5 (2 × C), 127.3, 128.0, 128.8, 129.1 (4 × CH), 133.2, 158.8, 161.7, 174.2 (4 × C). HRMS-FAB: m/z calcd for C13H11N2O2: 227.0822; found: 227.0825 [MH+].

14

Typical ProcedureSynthesis of 3-(2-Phenylethenyl)-5 H -isoxazolo[4,3- c ]pyridin-4-one (14a)
To 3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one (6, 100 mg, 0.66 mmol) in THF (20 mL) at -78 ˚C under N2 was added BuLi (0.6 mL of a 2.5 M solution in hexanes, 1.45 mmol) and the solution stirred for 1 h before benzaldehyde (1.0 mL, 0.99 mmol) was added. Stirring was continued for 5 min at -78 ˚C, before the mixture was quenched with H2O (20 mL), acidified with HCl (2 M, 20 mL) and extracted with EtOAc (2 × 30 mL). The combined organic layers were washed with brine (30 mL), dried (MgSO4), filtered, and evaporated under reduced pressure to a yellow oil purified by silica column chromatography, eluting with EtOAc-light PE (bp 40-60 ˚C) (1:1 v/v) to afford hydroxy adduct 13a (106 mg, 63%), pale yellow solid; mp 180-182 ˚C. IR (CH2Cl2):
νmax = 3395, 3131, 2962, 1675, 1643, 1457 cm. ¹H NMR [400 MHz, (CD3)2SO]: δ = 3.55 (2 H, d, J = 7.7 Hz, CHCH 2 ), 5.19 (1 H, m, CH2CH), 5.74 (1 H, d, J = 4.9 Hz, CHOH), 6.38 (1 H, d, J = 7.6 Hz, NHCHCH), 7.15 (1 H, dd, J = 7.6, 5.7 Hz, NHCH), 7.39-7.46 (5 H, m, ArCH), 10.15 (1 H, br, NH). ¹³C NMR [100 MHz, (CD3)2SO]: δ = 36.9 (CH2), 70.4, 92.6 (2 × CH), 108.5 (C), 125.6, 127.3, 128.2, 134.1 (4 × CH), 144.4, 157.3, 158.9, 174.8 (4 × C). HRMS (EI):
m/z calcd for C14H13N2O3: 257.0921; found: 257.0924 [MH+]. To 13a (130 mg, 0.51 mmol) in PhMe (30 mL) was added TsOH (96 mg, 0.51 mmol) and the mixture heated at reflux overnight under Dean-Stark conditions. Water (20 mL) was added to the cooled mixture, and it was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with brine (50 mL), dried (MgSO4), filtered, and evaporated under reduced pressure to leave title compound 14a, yellow solid (86 mg, 71%); mp 217-218 ˚C. IR (CH2Cl2): νmax = 3131, 2922, 1672, 1643, 1569, 1457 cm. ¹H NMR [400 MHz, (CD3)2SO]: δ = 6.38, 7.15 (each 1 H, d, J = 7.5 Hz, NHCH=CH), 7.42-7.51 (3 H, m, ArCH), 7.56 (1 H, d, J = 16.4 Hz, PhCH=CH), 7.75 (2 H, m, ArCH), 8.21 (1 H, d, J = 16.4, PhCH=CH), 10.95 (1 H, br, NH). ¹³C NMR [100 MHz, (CD3)2SO]: δ = 95.1 (CH), 107.8 (C), 112.6, 128.2, 128.9, 130.3 (4 × CH), 135.2 (C), 135.9, 139.9 (2 × CH), 158.3, 159.9, 171.8 (3 × C). HRMS (EI): m/z calcd for C14H10N2O2: 238.0741; found: 238.0741 [M+].

16

Crystallographic data for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. 752383 (13a) and 752384 (19). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (1223)336033 or e-mail: deposit@ccdc.cam.ac.uk].